Literature DB >> 3094142

[Meningococcal epidemic in a boarding school: a rifampicin-resistant secondary case while under chemoprophylaxis].

G Schubiger, J Munzinger, C Dudli, U Wipfli.   

Abstract

An epidemic of meningococcal disease after an influenza outbreak in a community of 49 boys (14-18 years) and 8 adults in a boarding-school is reported. The first patient died with all symptoms of the Waterhouse-Friderichsen syndrome. Several hours later, two other boys developed severe septicemia with meningitis and meningitis respectively. N. meningitidis group B susceptible to penicillin and rifampin was isolated. Within the next 8 hours, chemoprophylaxis with rifampin (600 mg twice daily) was started and maintained for 4 days for the whole community. Throat cultures had not been obtained before prophylaxis. Ten other symptomatic boys were admitted to the hospital and treated by penicillin infusion. The results of blood and cerebrospinal fluid cultures were negative, and treatment was therefore discontinued. Five days after the death of the first boy, another boy died with full-blown Waterhouse-Friderichsen syndrome while on chemoprophylaxis. The neisseriae isolated from this patient were rifampin-resistant. Serological investigations in all patients admitted to hospital revealed the existence of concomitant epidemic infection with influenza A and B in this school. We assume that the viral infection made way for the outbreak of the meningococcal disease and for the high rate of secondary meningococcal infection. Chemoprophylaxis with rifampin should not be continued for longer than 2 to 3 days, otherwise the risk of occurrence of rifampin resistant strains of N. meningitidis increases. Hitherto such strains have rarely been isolated in clinically manifest disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3094142

Source DB:  PubMed          Journal:  Schweiz Med Wochenschr        ISSN: 0036-7672


  5 in total

Review 1.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Serological study of meningococcal isolates in Switzerland and France 1980-1986.

Authors:  P Calain; J Poolman; W Zollinger; G Sperber; D Bitter-Suermann; R Auckenthaler; B Hirschel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-12       Impact factor: 3.267

3.  The association of meningococcal disease with influenza in the United States, 1989-2009.

Authors:  Jessica Hartman Jacobs; Cécile Viboud; Eric Tchetgen Tchetgen; Joel Schwartz; Claudia Steiner; Lone Simonsen; Marc Lipsitch
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

Review 4.  Potential Impact of Co-Infections and Co-Morbidities Prevalent in Africa on Influenza Severity and Frequency: A Systematic Review.

Authors:  Adam L Cohen; Meredith McMorrow; Sibongile Walaza; Cheryl Cohen; Stefano Tempia; Marissa Alexander-Scott; Marc-Alain Widdowson
Journal:  PLoS One       Date:  2015-06-11       Impact factor: 3.240

Review 5.  Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness.

Authors:  John F Brundage
Journal:  Lancet Infect Dis       Date:  2006-05       Impact factor: 25.071

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.